4LI P,KAWACHI H,MORIOKA T,et al.Suppressive effects of sairei-to on mAb 1-22-3 induced glomerulonephritis:analysis of effective components[J].Pathol Int,1997,47:430-435.
5KATO M,PU MY,ISOBE KI,et al.Characterization of the immunoregulatory action of saikosaponin-d[J].Cell Immunol,1994,159:15-25.
6KATO M,PU MY,ISOBE KI,et al.Cell type-oriented differential modulatory actions of saikosaponin-d on growth responses and DNA fragmentation of lymphocytes triggered by receptor-mediated and receptor-bypassed[J].Pathway,1995,29:207-213.
7KAWACHI H,ORIKASA M,MATSUI K,et al.Epitope-specific induction of mesangial lesions with proteinuria by a MoAb against mesangial cell surface antigen[J].Clin Exp Immunol,1992,88(3):399-404.
8GONLUSEN G,ERGIN M,PAYDAS S,et al.The expression of cytoskeletal proteins(alpha-SMA,vimentin,desmin) in kidney tissue:a comparison of fetal,normal kidneys,and glomerulonephritis[J].Urol Nephrol,2001,33:299-305.
9FUJIGAKI Y,SUN DF,FUJIMOTO T,et al.Mechanisms and kinetics of Bowman's epithelial-myofibroblast transdifferentiation in the formation of glomerular crescents[J].Nephron,2002,92:203-212.
10PETERS H,BORDER W A,NOBLE N A.Targeting TGF-beta overexpression:maximizing the antifibrotic actions of angiotensin Ⅱ blockade in anti-Thy1 glomerulonephritis[J].Nephrol Dial Transplant,1999,14(Suppl 4):22-23.
